RCC is also characterized by significant accumulations of polyunsaturated fatty acids in association with increased expression of stearoyl-CoA desaturase (SCD1) and FA elongase 2 and 5 [149], as well as metabolic heterogeneity that may allow for subtyping of cancers and prediction of clinical outcomes [150]. This evidence concerns the gene SCD and renal cell carcinoma.